Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Papaveretum [cns narcotic] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Papaveretum (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Papaveretum [anesthesia] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Papaveretum (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Papaveretum 10mg/1mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Papaveretum (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Papaveretum 20mg/1mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Papaveretum (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Papaveretum 15.4mg/hyoscine 400mcg injection solution 1mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Papaveretum (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Papaveretum BP 15.4mg/1mL injection (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Papaveretum (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Papaveretum BP 7.7mg/1mL injection (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Papaveretum (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Papaveretum injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Papaveretum (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Mixed opium alkaloids |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Papaveretum (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing papaveretum and scopolamine hydrobromide |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Papaveretum (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing papaveretum (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Papaveretum (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Aspirin+papaveretum 500mg/7.71mg dispersible tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Papaveretum (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Aspirin+papaveretum 500mg/10mg dispersible tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Papaveretum (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing aspirin and papaveretum (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Papaveretum (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Aspirin+papaveretum 500mg/10mg dispersible tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Papaveretum (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Papaveretum 10mg/1mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Papaveretum (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Papaveretum 20mg/1mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Papaveretum (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely papaveretum 15.4 milligram/1 milliliter and scopolamine hydrobromide 400 microgram/1 milliliter conventional release solution for injection ampule |
Has precise active ingredient |
False |
Papaveretum (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely papaveretum 15.4 milligram/1 milliliter and scopolamine hydrobromide 400 microgram/1 milliliter conventional release solution for injection ampule |
Has basis of strength substance (attribute) |
False |
Papaveretum (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing papaveretum and scopolamine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Papaveretum (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing papaveretum and scopolamine in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Papaveretum (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only aspirin and papaveretum (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Papaveretum (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only papaveretum (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Papaveretum (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only papaveretum and scopolamine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Papaveretum (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only papaveretum and scopolamine in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Papaveretum (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Hyoscine hydrobromide 400 microgram/mL and papaveretum 15.4 mg/mL solution for injection |
Has basis of strength substance (attribute) |
False |
Papaveretum (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Hyoscine hydrobromide 400 microgram/mL and papaveretum 15.4 mg/mL solution for injection |
Has precise active ingredient |
False |
Papaveretum (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Hyoscine hydrobromide 400 microgram/mL and papaveretum 15.4 mg/mL solution for injection |
Has precise active ingredient |
True |
Papaveretum (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Hyoscine hydrobromide 400 microgram/mL and papaveretum 15.4 mg/mL solution for injection |
Has basis of strength substance (attribute) |
True |
Papaveretum (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |